c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF.
c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF.
复制标题
DOI:
10.1016/j.jhep.2011.02.036
复制
发表时间:
2011-12
影响因子:
25.7
通讯作者:
Sarkar, Devanand
中科院分区:
文献类型:
--
作者:
Yoo, Byoung Kwon;Gredler, Rachel;Chen, Dong;Santhekadur, Prasanna K.;Fisher, Paul B.;Sarkar, Devanand
Understanding the molecular pathogenesis of hepatocellular carcinoma (HCC) would facilitate development of targeted and effective therapies for this fatal disease. We recently demonstrated that the cellular transcription factor Late SV40 Factor (LSF) is overexpressed in more than 90% of human HCC cases, compared to normal liver, and plays a seminal role in hepatocarcinogenesis. LSF transcriptionally upregulates osteopontin (OPN) that plays a significant role in mediating the oncogenic function of LSF. The present study aims at a better understanding of LSF function by analyzing the signaling pathway modulated by LSF. Phospho-receptor tyrosine kinase (RTK) array was performed to identify which receptor tyrosine kinases are activated by LSF. Immunohistochemical analysis using tissue microarray was performed to establish correlation among LSF, OPN and phospho-c-Met levels in HCC patients. Co-immunoprecipitation analysis was performed to check OPN-induced CD44 and c-Met interaction. Inhibition studies using chemicals and siRNAs were performed in vitro and in vivo using nude mice xenograft models to establish the importance of c-Met activation in mediating LSF function. Secreted OPN, induced by LSF, activates c-Met via a potential interaction between OPN and its cell surface receptor CD44. A significant correlation was observed among LSF, OPN and activated c-Met levels in HCC patients. Chemical or genetic inhibition of c-Met resulted in profound abrogation of LSF-mediated tumorigenesis and metastasis in nude mice xenograft studies. The present findings elucidate a novel pathway of c-Met activation during hepatocarcinogenesis and support the rationale of using c-Met inhibitors as potential HCC therapeutics.
登录
查看更多内容
影响因子:
64.8
作者:
Boccaccio, C;Sabatino, G;Comoglio, PM
通讯作者:
Comoglio, PM
影响因子:
7.8
作者:
Wang, R;Ferrell, DL;Faouzi, S;Maher, JJ;Bishop, JM
通讯作者:
Bishop, JM
影响因子:
254.7
作者:
Parkin, DM;Bray, F;Pisani, P
通讯作者:
Pisani, P
影响因子:
3.3
作者:
Orian-Rousseau, Veronique;Morrison, Helen;Ponta, Helmut
通讯作者:
Ponta, Helmut
影响因子:
10.5
作者:
Orian-Rousseau, V;Chen, LF;Ponta, H
通讯作者:
Ponta, H